Cutaneous Leishmaniasis

DBCOND0028439InfectionsSkin and Subcutaneous Tissue Diseases

Cutaneous Leishmaniasis is the indication for 1 drug in DrugBank. It is covered by 1 curated, structured indication.

Also known as
Leishmaniasis, Cutaneous · Old World Cutaneous Leishmaniasis · Leishmaniasis; American · Leishmaniasis, American
Classified under
Indicated drugs

Resolves to

Vocabularies
MeSHM0025563ICD-10B55.1SNOMED CT186804001MedDRA10011668UMLSC0023283

What you can answer from here — as of October 24, 2026

1Indicated drugWith each drug's targets and mechanism
Listed above
1Structured indicationPopulation, line of therapy, route and combination as fields, not prose
Sign in
80Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1Drug reporting it as an adverse effectWith incidence where the label states it
Sign in

Which approved drugs for Cutaneous Leishmaniasis share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In